124 related articles for article (PubMed ID: 25720804)
1. Effects of the angiotensin II Ala-scan analogs in erythrocytic cycle of Plasmodium falciparum (in vitro) and Plasmodium gallinaceum (ex vivo).
Silva AF; de Souza Silva L; Alves FL; Der TorossianTorres M; de SáPinheiro AA; Miranda A; LaraCapurro M; Oliveira VX
Exp Parasitol; 2015 Jun; 153():1-7. PubMed ID: 25720804
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II restricted analogs with biological activity in the erythrocytic cycle of Plasmodium falciparum.
Torres MD; Silva AF; de Souza Silva L; de Sá Pinheiro AA; Oliveira VX
J Pept Sci; 2015 Jan; 21(1):24-8. PubMed ID: 25420772
[TBL] [Abstract][Full Text] [Related]
3. Highly potential antiplasmodial restricted peptides.
Marcelo Der Torossian T; Silva AF; Alves FL; Capurro ML; Miranda A; Vani Xavier O
Chem Biol Drug Des; 2015 Feb; 85(2):163-71. PubMed ID: 24800635
[TBL] [Abstract][Full Text] [Related]
4. New linear antiplasmodial peptides related to angiotensin II.
Silva AF; Torres MD; Silva Lde S; Alves FL; Pinheiro AA; Miranda A; Capurro ML; Oliveira VX
Malar J; 2015 Nov; 14():433. PubMed ID: 26537730
[TBL] [Abstract][Full Text] [Related]
5. Antiplasmodial activity study of angiotensin II via Ala scan analogs.
Silva AF; Bastos EL; Torres MD; Costa-da-Silva AL; Ioshino RS; Capurro ML; Alves FL; Miranda A; Vieira Rde F; Oliveira VX
J Pept Sci; 2014 Aug; 20(8):640-8. PubMed ID: 24817179
[TBL] [Abstract][Full Text] [Related]
6. Anti-plasmodial activity of bradykinin and analogs.
Silva AF; Alves FL; Pedron CN; Torres MD; Silva LS; Pinheiro AA; Miranda A; Oliveira VX
Bioorg Med Chem Lett; 2015 Aug; 25(16):3311-3. PubMed ID: 26077496
[TBL] [Abstract][Full Text] [Related]
7. A study of the anti-plasmodium activity of angiotensin II analogs.
Chamlian M; Bastos EL; Maciel C; Capurro ML; Miranda A; Silva AF; Torres MD; Oliveira VX
J Pept Sci; 2013 Sep; 19(9):575-80. PubMed ID: 23893516
[TBL] [Abstract][Full Text] [Related]
8. Evidences for the action mechanism of angiotensin II and its analogs on Plasmodium sporozoite membranes.
Torres MD; Silva AF; Alves FL; Capurro ML; Miranda A; Cordeiro RM; Oliveira Junior VX
J Pept Sci; 2016 Mar; 22(3):132-42. PubMed ID: 26856687
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction.
Silva AF; Torres MT; Silva LS; Alves FL; de Sá Pinheiro AA; Miranda A; Capurro ML; de la Fuente-Nunez C; Oliveira VX
Sci Rep; 2017 Oct; 7(1):14326. PubMed ID: 29085013
[TBL] [Abstract][Full Text] [Related]
10. Impairment of the Plasmodium falciparum erythrocytic cycle induced by angiotensin peptides.
Saraiva VB; de Souza Silva L; Ferreira-DaSilva CT; da Silva-Filho JL; Teixeira-Ferreira A; Perales J; Souza MC; Henriques Md; Caruso-Neves C; de Sá Pinheiro AA
PLoS One; 2011 Feb; 6(2):e17174. PubMed ID: 21364758
[TBL] [Abstract][Full Text] [Related]
11. Anti-plasmodium activity of angiotensin II and related synthetic peptides.
Maciel C; de Oliveira Junior VX; Fázio MA; Nacif-Pimenta R; Miranda A; Pimenta PF; Capurro ML
PLoS One; 2008 Sep; 3(9):e3296. PubMed ID: 18820728
[TBL] [Abstract][Full Text] [Related]
12. A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.
Korde R; Bhardwaj A; Singh R; Srivastava A; Chauhan VS; Bhatnagar RK; Malhotra P
J Med Chem; 2008 Jun; 51(11):3116-23. PubMed ID: 18461922
[TBL] [Abstract][Full Text] [Related]
13. Xanthurenic acid induces gametogenesis in Plasmodium, the malaria parasite.
Garcia GE; Wirtz RA; Barr JR; Woolfitt A; Rosenberg R
J Biol Chem; 1998 May; 273(20):12003-5. PubMed ID: 9575140
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the antimalarial activity of new compounds against Plasmodium falciparum in vitro, and Plasmodium berghei in vivo.
Tedlaouti F; Gasquet M; Delmas F; Timon-David P; Madadi NE; Vanelle P; Maldonado J
J Pharm Belg; 1990; 45(5):306-10. PubMed ID: 2086754
[TBL] [Abstract][Full Text] [Related]
15. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
[TBL] [Abstract][Full Text] [Related]
16. New syntheses and potential antimalarial activities of new 'retinoid-like chalcones'.
Valla A; Valla B; Cartier D; Le Guillou R; Labia R; Florent L; Charneau S; Schrevel J; Potier P
Eur J Med Chem; 2006 Jan; 41(1):142-6. PubMed ID: 16274873
[TBL] [Abstract][Full Text] [Related]
17. Synthetic indole and melatonin derivatives exhibit antimalarial activity on the cell cycle of the human malaria parasite Plasmodium falciparum.
Schuck DC; Jordão AK; Nakabashi M; Cunha AC; Ferreira VF; Garcia CR
Eur J Med Chem; 2014 May; 78():375-82. PubMed ID: 24699367
[TBL] [Abstract][Full Text] [Related]
18. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimalarial activity of new 3-arylquinoxaline-2-carbonitrile derivatives.
Zarranz B; Jaso A; Aldana I; Monge A; Maurel S; Deharo E; Jullian V; Sauvain M
Arzneimittelforschung; 2005; 55(12):754-61. PubMed ID: 16430030
[TBL] [Abstract][Full Text] [Related]
20. Sulfated cyclodextrins inhibit the entry of Plasmodium into red blood cells. Implications for malarial therapy.
Crandall IE; Szarek WA; Vlahakis JZ; Xu Y; Vohra R; Sui J; Kisilevsky R
Biochem Pharmacol; 2007 Mar; 73(5):632-42. PubMed ID: 17166484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
